BlackRock, Inc. 13D and 13G filings for Rocket Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | BlackRock Inc. BLK | 5,930,178 6.600% | 342,643 (+6.13%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | BlackRock Inc. BLK | 5,587,535 7.100% | 2,248,066 (+67.32%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | BlackRock Inc. BLK | 3,339,469 5.200% | 3,339,469 (New Position) | Filing |